Table 2 .
Author | Regime | Success rate | Outcomes | |||
---|---|---|---|---|---|---|
Death | Surgery | Other | ||||
Milito et al31 | MCT feed, rarely TPN, cotrimoxazole if lymphocyte count <1,000 per μl. Surgery if drain output >1,000ml in 24h for >48h | 22/50 | 26 | 2 (pleuroperitoneal shunt) | ||
Alamdari et al25 | Two-week NBM or fat-restricted feed supplemented with MCT; TPN; tube thoracostomy; octreotide 100μg three times daily | 46/98 | 26 | 26 (PRFG pleurodesis) | ||
Weijs et al20 | Low-fat feed for 7 days (if drain output <500ml) | 40/61 | 1 | 20 (TPN) | ||
TPN for 7 days (if drain output >500ml) | 11/15 | 4 | ||||
TPN and low-fat feed for 7 days | 1/1 | |||||
Brinkmann et al33 | TPN, chest drain for >48h | 2/17 | 15 | |||
Miao et al32 | NBM, TPN and octreotide | 23/34 | 11 | |||
Kim et al29 | NBM, TPN; ± pleurodesis and octreotide if clinically not improving | 43/54 | 11 | |||
Fujita and Daiko13 | TPN only | 2/5 | 3 | |||
TPN and octreotide 100μg TDS | 13/15 | 2 | ||||
Li et al21 | Low-fat feed, chest drain, protein supplementation if needed | 48-h trial | 45/186 | 6 | 135 | |
2-week trial | 77/120 | 3 | 36 | 4 (recurrence) | ||
Shah et al28 | NBM, ± additional chest drain ± TPN ± elemental feeds ± octreotide ± pleurodesis | 13/34 | (6) | 21 | ||
Schumacher et al35 | TPN and albumin infusions | 1/2 | 1 | |||
Lagarde et al5 | NBM, TPN. If drain <500ml per day, started on low-fat diet | 16/20 | 4 | |||
Rao et al30 | NBM, TPN, chest drain, octreotide in one patient | 5/14 | 2 | 7 | ||
Bonavina et al36 | 2-week trial of NBM, TPN and chest drain. Octreotide and ethylephrine given in 2 | 0/3 | 3 | |||
Merigliano et al19 | NBM, TPN, chest drain | 4/11 | 7 | |||
Alexiou et al37 | NBM, TPN, chest drain | 13/21 | 4 | 4 | ||
Dugue et al38 | 12-day trial of TPN, chest drain | 14/23 | 9 | |||
Bolger et al39 | TPN, chest drain | 3/11 | 4 | 3 | 1 (recurrence) | |
Total | 394/795 (49.6%) | 20 (2.5%) | 328 (41.3%) | 53 (6.6%) |
MCT, medium chain triglycerides; NBM, nil by mouth; PRFG, platelet-rich fibrin glue; TPN, total parenteral nutrition.